Intervention Review

Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation

  1. Lior H Katz1,*,
  2. Ran Tur-Kaspa2,
  3. Daniel G Guy3,
  4. Mical Paul4

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 7 JUL 2010

Assessed as up-to-date: 11 APR 2009

DOI: 10.1002/14651858.CD006005.pub2

How to Cite

Katz LH, Tur-Kaspa R, Guy DG, Paul M. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD006005. DOI: 10.1002/14651858.CD006005.pub2.

Author Information

  1. 1

    Sheba Medical Center, Gastroenterology Department, Ramat-Gan, Israel

  2. 2

    Rabin Medical Center - Beilison Campus, Department of Internal Medicine D, Petah Tigva, Israel

  3. 3

    Sackler School of Medicine, Tel Aviv, Israel

  4. 4

    Sackler Faculty of Medicine, Infectious Diseases Unit, Tel Aviv, Israel

*Lior H Katz, Gastroenterology Department, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, 52621, Israel. liorshlomit@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 7 JUL 2010

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vivek Kak, Vidya Sundareshan, Jignesh Modi, Nancy Misri Khardori, Immunotherapies in Infectious Diseases, Medical Clinics of North America, 2012, 96, 3, 455

    CrossRef

  2. 2
    Jennifer L. Hsu, Nasia Safdar, Polyclonal Immunoglobulins and Hyperimmune Globulins in Prevention and Management of Infectious Diseases, Infectious Disease Clinics of North America, 2011, 25, 4, 773

    CrossRef

  3. 3
    Basile Njei, Sushil Kumar, Eugene J Kongnyuy, Adefovir dipivoxil versus other antiviral drugs for chronic hepatitis B, The Cochrane Library,